US loss of exclusivity · Immunology

Stelara

Johnson & Johnson

2025US biosimilars on sale
2025Today: 20262037
2025 worldwide sales
$6.1B
Date basis
Biosimilars launched
US biosimilars
Copies on the US market
Medicare price
−66%, 2026 only
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Stelara timeline →